This symposium considered the potential of probiotics to revolutionize HIV prevention. With this new technology, lactobacilli are used to produce antiviral compound that would function as long-term, self-replicating delivery systems and combat reproductive tract infections. It explored implications for probiotic approaches and investigated a repeated low dose challenge model using a live lactobacillus microbicide. This symposium also discussed lessons from the microbicide field, the need to build support for probiotics in HIV prevention, and the regulatory requirements for developing this technology.

Download Full Symposium Report